Gilead Sciences develops and markets therapies to treat and prevent life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing its presence in the oncology market via acquisitions, led by CAR-T cell therapy Yescarta/Tecartus (from Kite) and breast and bladder cancer therapy Trodelvy (from Immunomedics).
Quick Stats
May 18, 202660.8
AI Score
BUY0.34
Volume Ratio
May 07, 2026
Next Earnings
14
+ve Days (30d)
16
-ve Days (30d)
GILD Stock Summary
Last updated May 18, 2026
GILD is currently trading at $130.47, positioned above its 200-day moving average of $127.94, indicating a long-term uptrend. The stock has a 52-week range of $100.23 to $157.29.
Technical Analysis: The 50-day moving average stands at $137.08, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 38.942, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.1, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates GILD at 60.8/100 with a BUY recommendation.
GILD (Gilead Sciences Inc) Indicators
Last updated May 18, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 38.942 |
| CMF (20) | -0.1 |
| ROC (10) | -2.532 |
| ADX (14) | 16.008 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -1.72 |
| AROONOSC (14) | 57.143 |
| WILLAMS %R (14) | -85.639 |
| MFI (14) | 49.001 |
GILD Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
GILD Price vs Max Options Open Interest
GILD Max Change In Options Open Interest
GILD Options - Sort by Max open Interest (near term)
18th May 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
GILD Daily Out of Money Options - Sort by Max open Interest (near term)
18th May 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
GILD Daily In the Money Options - Sort by Max open Interest (near term)
18th May 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
GILD Most Active Options by Volume(near term)
18th May 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Gilead Sciences Inc is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
GILD Moving Averages Analysis
Gilead Sciences Inc has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on May 18, 2026
GILD (Gilead Sciences Inc) Simple Moving Averages
Moving Averages are last updated May 18, 2026
| Days | MA |
|---|---|
| 10 | 132.88 |
| 20 | 132.0 |
| 30 | 134.43 |
| 50 | 137.08 |
| 100 | 137.42 |
| 200 | 127.94 |
GILD Fundamental Analysis
| P/E (Forward) | 15.0376 |
| P/E (Trailing) | 17.9429 |
| Market Cap ($) | 164.0 billion |
| Earnings/Share ($) | 7.36 |
| Net Proft Margin (%) | 0.3099 |
| Dividend/Share ($) | 3.19 |
| EPS Estimate Current Year ($) | -0.8235 |
| EPS Estimate Next Year ($) | 9.6838 |
| WallStreet Target Price ($) | 157.9643 |
| Most Recent Quarter |